BIIB vs CRWV · P/E 21, rev $9.89B vs rev $5.13B
Biogen Inc (BIIB) versus CoreWeave, Inc. Class A Common Stock (CRWV) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
CoreWeave, Inc. Class A Common Stock (CRWV) is a software - infrastructure company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported CRWV revenue for 2025-12-31 was $5.13B. Net income was -$1.17B. Revenue was up 167.9% from 2024-12-31 to 2025-12-31. CRWV currently screens at market cap $81.60B.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. CRWV currently screens at market cap $81.60B.
Not investment advice. Open the BIIB and CRWV stock pages for the full models.
Not investment advice.